A population-based cohort study of glioblastoma (WHO grade 4 gliomas) in Ontario: continued improvement in care over 25 years
Taslimi S, Brogly S, Hanna T, Shellenberger J, Whitehead M, Alkins RD. World Neurosurg. 2025; Feb 21 [Epub ahead of print].
Background — Estimates of the future prevalence of childhood cancer are informative for health system planning but are underutilized. We describe the development of a pediatric oncology microsimulation model for prevalence (POSIM-Prev) and illustrate its application to produce projections of incidence, survival, and limited-duration prevalence of childhood cancer in Ontario, Canada, until 2040.
Methods — POSIM-Prev is a population-based, open-cohort, discrete-time microsimulation model. The model population was updated annually from 1970 to 2040 to account for births, deaths, net migration, and incident cases of childhood cancer. Prevalent individuals were followed until death, emigration, or the last year of simulation. Median population-based outcomes with 95% credible intervals (CrIs) were generated using Monte Carlo simulation. The methodology to derive model inputs included generalized additive modeling of cancer incidence, parametric survival modeling, and stochastic population forecasting. Individual-level data from provincial cancer registries for years 1970 to 2019 informed cancer-related model inputs and internal validation.
Results — The number of children (aged 0–14 y) diagnosed with cancer in Ontario is projected to rise from 414 (95% CrI: 353–486) in 2020 to 561 (95% CrI: 481–653) in 2039. The 5-y overall survival rate for 2030–2034 is estimated to reach 90% (95% CrI: 88%–92%). By 2040, 24,088 (95% CrI: 22,764–25,648) individuals with a history of childhood cancer (diagnosed in Ontario or elsewhere) are projected to reside in the province. The model accurately reproduced historical trends in incidence, survival, and prevalence when validated.
Conclusions — The rising incidence and prevalence of childhood cancer will create increased demand for both acute cancer care and long-term follow-up services in Ontario. The POSIM-Prev model can be used to support long-range health system planning and future health technology assessments in jurisdictions that have access to similar model inputs.
Highlights
Moskalewicz A, Gupta S, Nathan PC, Pechlivanoglou P. Med Decis Making. 2025; 272989X251314031. Epub 2025 Feb 4.
The ICES website uses cookies. If that’s okay with you, keep on browsing, or learn more about our Privacy Policy.